Posts by tag
global health
Charles Balch Treated Thousands of Patients. He Says That’s Not His Greatest Work.
If you try to list everything Charles Balch has done, you quickly realize the list does not help you understand the man. He has led some of the most important institutions in oncology. He has built systems that are now…
Mission 2027: Mission is Possible
The Minister of Health of Rwanda Dr Sabin Nsanzimana on medicine, 1994 genocide against the Tutsi, leadership, workforce, technology, and the ambition to eliminate cervical cancer The latest interview for CancerWorld features Dr Sabin Nsanzimana, Minister of Health of Rwanda, physician, epidemiologist,…
CancerWorld #115 (May 2026)
In oncology, progress is measured in survival rates, response curves, and treatment gains. But those numbers rest on a quieter assumption: that health systems can deliver what science makes possible. When they cannot, progress becomes uneven—not in discovery, but in…
Psycho-Oncology at a Crossroads: From Global Recognition to Real-World Impact
The launch of World Psycho-Oncology Day signals growing momentum behind psychosocial care in cancer, but without structural change, millions of patients will continue to go without the support they need. With the announcement of World Psycho-Oncology Day (WPOD), to be…
Isabel Mestres: The Doer
Global health has become very good at diagnosing problems but far less effective at implementing solutions. That gap is where Isabel Mestres has built her career. As CEO of City Cancer Challenge, she is known not as a theorist or…
From Dalian to Houston and Back to Yemen: Bridging the Global Oncology Divide
A Global Summit, a Personal Reckoning At the European Society for Medical Oncology (ESMO) Leadership Summit in Singapore, discussions moved rapidly from antibody–drug conjugates to next-generation sequencing and the expanding role of immunotherapy. Clinical trial curves filled large screens, and…
The Day Immunotherapy Went Off-Patent
In oncology, some milestones arrive with applause. Others arrive quietly. This year, one of the most important cancer drugs of the modern era begins to lose its monopoly. Nivolumab, one of the first PD-1 inhibitors to reach patients, is set…
Bente Mikkelsen: “Success is Something We Build Together”
From the bedside to global reform, and why equity must be engineered, not hoped for “I think I chose medicine because it gave all the opportunities to address people, both at a national level, but also internationally. And it’s a…
CancerWorld #113 (March 2026)
Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…
Cary Adams: A Career of Change, Changing Careers.
He is passionate about the mission of UICC. *** When Cary Adams tells the story of how his career began, it doesn’t start with a calling in oncology. It starts with a teenage conversation about what might matter in the…